Core Insights - ST Yilianzhong's stock closed at 4.37 yuan, up 2.58%, with a latest price-to-book ratio of 6.60, marking a new low in 25 days and a total market capitalization of 1.879 billion yuan [1] - As of the first quarter of 2025, only one institution holds shares in ST Yilianzhong, with a total of 69.6067 million shares valued at 294 million yuan [1] - The company specializes in digital medical insurance, digital healthcare, digital social security, digital technology, and digital services, with key products including customized software, technical services, system integration, and insurance brokerage [1] Financial Performance - In the first quarter of 2025, the company reported operating revenue of 59.3623 million yuan, a year-on-year increase of 21.49%, while net profit was -26.2625 million yuan, a year-on-year decline of 34.59%, with a gross profit margin of 48.01% [2] Industry Comparison - ST Yilianzhong's price-to-earnings (P/E) ratio (TTM) is -63.93, and its static P/E ratio is -43.42, with a price-to-book ratio of 6.60 and a total market capitalization of 1.879 billion yuan [3] - The industry average P/E ratio (TTM) is 76.02, with a static P/E ratio of 78.49 and a price-to-book ratio of 5.34, while the industry median P/E ratio (TTM) is 81.68 [3]

Group 1 - The core business of the company includes digital medical insurance, digital healthcare, digital social security, digital technology, and digital services [1] - The company has received several awards for its achievements in blockchain technology and digital health initiatives, including the FISCOBCOS Open Source Ecological Excellence Contribution Award and recognition at the 2023 Digital China Summit [1] - As of the first quarter of 2025, the company reported a revenue of 59.36 million yuan, a year-on-year increase of 21.49%, but a net loss of approximately 26.26 million yuan, representing a year-on-year decline of 34.59% [2] Group 2 - The company's latest closing price was 4.07 yuan, with a market capitalization of 1.75 billion yuan and a price-to-book ratio of 6.14 [1] - The company has only one institutional investor holding a total of 69.67 million shares, valued at approximately 29.4 million yuan [1] - The company's sales gross margin stands at 48.01% [2]

Group 1 - The core business of the company includes digital medical insurance, digital healthcare, digital social security, digital technology, and digital services [1] - As of April 10, 2025, the number of shareholders is 19,004, a decrease of 687 from the previous count, with an average holding value of 352,800 yuan and an average holding of 27,600 shares [1] - The company has received several awards for its achievements in blockchain technology and digital health initiatives, including the FISCOBCOS Open Source Ecological Excellence Contribution Award and recognition at the 2023 Digital China Summit [1] Group 2 - The latest financial report for Q3 2024 shows the company achieved operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, a year-on-year decline of 153.10% [2] - The company's gross profit margin stands at 46.38% [2] Group 3 - The company's price-to-earnings (P/E) ratio (TTM) is -10.79, with a static P/E ratio of 46.31 and a price-to-book (P/B) ratio of 5.99, while the total market capitalization is 1.716 billion yuan [3] - The industry average P/E ratio is 67.04, with a static P/E of 73.31 and a P/B ratio of 4.99, while the industry median P/E is 78.26 and the median P/B is 3.58 [3]

Core Viewpoint - ST Yilianzhong's stock closed at 4.04 yuan, down 1.70%, with a latest price-to-book ratio of 6.07 and a total market capitalization of 1.737 billion yuan [1] Financial Performance - For the third quarter of 2024, the company reported operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net profit of -67,993,078.91 yuan, reflecting a year-on-year decline of 153.10%, with a gross profit margin of 46.38% [2] Business Overview - The main business of Yilianzhong Information Technology Co., Ltd. includes digital medical insurance, digital healthcare, digital social security, digital technology, and digital services. Key products consist of customized software and IC, technical services, system integration, hardware, insurance brokerage, and other services [1] - The company has received several awards for its achievements in blockchain technology and digital health initiatives, including the FISCOBCOS Open Source Ecological Excellence Contribution Award and recognition at the 2023 Digital China Construction Summit [1] Market Position - The company's price-to-earnings ratio (TTM) is -10.93, with a static PE of 46.89 and a price-to-book ratio of 6.07, compared to the industry average PE of 70.88 and a market capitalization of 1.216 billion yuan [3]

Core Insights - ST Yilianzhong's stock closed at 4.08 yuan, up 1.24%, with a latest price-to-book ratio of 6.13 and a total market capitalization of 1.754 billion yuan [1] - The company has 19,004 shareholders as of April 10, 2025, a decrease of 687 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Company Overview - ST Yilianzhong focuses on digital healthcare, digital medical services, digital social security, digital technology, and digital services [1] - Key products include customized software and IC, technical services, system integration, hardware, insurance brokerage, and other services [1] - The company has received several awards for its blockchain technology achievements and innovative digital health solutions [1] Financial Performance - For the third quarter of 2024, the company reported revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, a year-on-year decline of 153.10% [2] - The sales gross margin stands at 46.38% [2] Market Comparison - ST Yilianzhong's price-to-earnings ratio (TTM) is -11.03, while the industry average is 72.15 [2] - The company's market capitalization is 1.754 billion yuan, compared to the industry median of 5.563 billion yuan [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and achievements of ST Yilianzhong, indicating a significant decline in revenue and net profit while showcasing various awards and recognitions in digital healthcare and technology [1][2] Group 2 - As of March 31, 2025, ST Yilianzhong had 19,691 shareholders, a decrease of 115 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in digital healthcare services, including digital medical insurance, digital healthcare, digital social security, and digital technology services, with products such as customized software, technical services, and system integration [1] - The company received the FISCOBCOS Open Source Ecological Excellence Contribution Award for its achievements in blockchain technology and was recognized for its innovative digital healthcare solutions at various national events [1] - The latest financial report for Q3 2024 shows a revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, reflecting a year-on-year decline of 153.10%, with a gross profit margin of 46.38% [2] - The company's price-to-earnings ratio (PE) is reported at -11.12 (TTM) and 47.70 (static), with a price-to-book ratio of 6.17 and a total market capitalization of 1.767 billion yuan [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of ST Yilianzhong, indicating a significant decline in revenue and net profit for the third quarter of 2024 compared to the previous year [2] - As of March 31, ST Yilianzhong's stock closed at 4.22 yuan, marking a 2.93% increase, with a latest price-to-book ratio of 6.34, which is the lowest in 238 days, and a total market capitalization of 1.815 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 11.04 million yuan on March 31, with a total inflow of 29.93 million yuan over the past five days, indicating a positive trend in fund movement [1] Group 2 - For the third quarter of 2024, ST Yilianzhong reported an operating income of 335 million yuan, reflecting a year-on-year decrease of 29.72%, and a net profit loss of approximately 67.99 million yuan, which is a 153.10% decline compared to the previous year [2] - The company's gross profit margin stands at 46.38%, which is a critical metric for assessing its profitability in the current market environment [2] - The company has received several accolades for its contributions to digital healthcare and technology, including awards for its blockchain achievements and innovative digital health applications [1]

Group 1 - ST Yilianzhong's stock closed at 3.9 yuan, up 3.17%, with a latest price-to-book ratio of 5.86 and a total market value of 1.677 billion yuan [1] - The net inflow of main funds on March 26 was 3.1041 million yuan, with a total inflow of 6.3381 million yuan over the past five days [1] - The company specializes in digital medical insurance, digital healthcare, digital social security, digital technology, and digital services [1] Group 2 - For the third quarter of 2024, the company reported operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, a year-on-year decline of 153.10% [2] - The company's sales gross margin was 46.38% [2] - The company has received several awards for its blockchain technology achievements and digital healthcare innovations [1][2]

Group 1 - ST Yilianzhong's stock closed at 3.76 yuan, down 3.84%, with a latest price-to-book ratio of 5.65 and a total market value of 1.617 billion yuan [1] - As of March 10, 2025, the number of shareholders for ST Yilianzhong increased to 20,440, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company specializes in digital medical insurance, digital healthcare, digital social security, digital technology, and digital services, with products including customized software, technical services, system integration, and insurance brokerage [1] Group 2 - For the third quarter of 2024, the company reported operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net profit of -67,993,078.91 yuan, a year-on-year decrease of 153.10%, with a gross profit margin of 46.38% [2] - The company's price-to-earnings ratio (TTM) is -10.17, while the industry average is 73.18, indicating significant underperformance compared to peers [2] - The company has received several awards for its achievements in blockchain technology and digital health innovation, including recognition at the Digital China Summit and the National Health Commission's digital health innovation competition [1][2]